| Names | |
|---|---|
| Preferred IUPAC name | 2-Methyl-6-nitro-1H-isoindole-1,3(2H)-dione |
| Other names | 4-Nitro-N-methylphthalimide N-Methyl-4-nitro-1H-isoindole-1,3(2H)-dione N-Methyl-4-nitroisobenzofuran-1,3-dione |
| Pronunciation | /ɛn-ˈmɛθɪl-ˈfaɪv-ˈnaɪtroʊ-ˈθælɪˌmaɪd/ |
| Identifiers | |
| CAS Number | 6687-07-6 |
| Beilstein Reference | 186145 |
| ChEBI | CHEBI:36605 |
| ChEMBL | CHEMBL589203 |
| ChemSpider | 12725048 |
| DrugBank | DB07765 |
| ECHA InfoCard | 100.045.088 |
| EC Number | 629-430-3 |
| Gmelin Reference | 110520 |
| KEGG | C19206 |
| MeSH | D017220 |
| PubChem CID | 97264 |
| RTECS number | OG6825000 |
| UNII | PT8A50QH3U |
| UN number | NA1993 |
| Properties | |
| Chemical formula | C9H6N2O4 |
| Molar mass | 274.18 g/mol |
| Appearance | Yellow powder |
| Odor | Odorless |
| Density | 1.51 g/cm3 |
| Solubility in water | Insoluble |
| log P | 0.09 |
| Vapor pressure | 0.0000141 mmHg at 25°C |
| Acidity (pKa) | 7.57 |
| Basicity (pKb) | 13.46 |
| Magnetic susceptibility (χ) | -33.9·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.626 |
| Dipole moment | 4.78 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 367.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -204.2 kJ/mol |
| Pharmacology | |
| ATC code | N02BA01 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and serious eye irritation, may cause respiratory irritation |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS06,GHS09 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P362+P364, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 1, Special: – |
| Flash point | 181.5 °C |
| Autoignition temperature | 533°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 640 mg/kg |
| LD50 (median dose) | LD50 (median dose): 640 mg/kg (rat, oral) |
| NIOSH | JN9263000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.05 mg/m3 |
| Related compounds | |
| Related compounds | N-Methylphthalimide 4-Nitrophthalimide N-Methyl-3-nitrophthalimide |
| Property | Manufacturer Interpretation |
|---|---|
| Product Name | N-Methyl-4-nitrophthalimide |
| IUPAC Name | 1-Methyl-3-nitro-1,3-dihydro-2H-isoindole-2,6-dione |
| Chemical Formula | C9H6N2O4 |
| Synonyms & Trade Names | N-Methyl-4-nitro-1H-isoindole-1,3(2H)-dione, 4-Nitro-N-methylphthalimide, 4-Nitro-N-methyl-1,3-dihydro-2H-isoindole-2,6-dione |
| CAS Number | 6246-78-0 |
| HS Code & Customs Classification | The harmonization of import/export classification for N-Methyl-4-nitrophthalimide is region-dependent. Most jurisdictions classify it under 2933.39, which covers other heterocyclic compounds with nitrogen hetero-atom(s) only. Regional and end-use variations often arise, particularly where product specificity is required for customs tariff purposes. Final harmonized classification relies on intended use, grade, and compound purity. The manufacturer typically provides a conformity document or letter of analysis to assist with customs clearance. |
Production of N-Methyl-4-nitrophthalimide relies on controlled nitration of a methylated phthalimide feedstock. Choice of nitration agent, solvent, temperature profile, and agitation rate set the balance between acceptable conversion and impurity control. Raw material traceability and reagent grade selection heavily affect downstream purification burden, since trace amines, incompletely nitrated byproducts, and color bodies may persist without rigorous upstream material qualification.
Process control hinges on consistent reagent addition, temperature monitoring, and quenching management. Manufacturing deviations, such as run-away exotherms or overdosing of nitration agents, trigger side-product formation including dinitro derivatives or N-formyl impurities. In-process controls target critical conversion ratios, color indices, and residual starting material thresholds rather than single-point endpoint analysis.
Final product purity, particle size, and moisture content are finalized by multi-stage purification, generally using recrystallization or phase-separation coupled to monitored drying protocols. These operations dictate batch reproducibility and handling ease, especially for grades intended for electronic or pharmaceutical intermediates. For other industrial applications, such as pigment or performance chemical intermediates, tolerance for colored trace impurities may be wider, but internal benchmarks still dictate minimum assay and impurity cap limits according to batch QC findings.
Release criteria are tied to application intent and customer specifications. The technical release can include purity by HPLC or titration, granulometry for formulation compatibility, and trace contaminant profiling when the application demands. Storage and handling reflect sensitivity to moisture (which may induce caking or hydrolysis in less pure/lower grade material), reinforcing the need for tightly sealed containers and controlled humidity environments as part of standard operating protocols.
The customs HS Code is confirmed prior to shipment, based on both the chemical identity and grade-specific end-use documentation. This approach helps customers avoid clearance delays and ensures regulatory compliance in export markets, reflecting the technical manufacturer’s experience in supporting chemical logistics at scale.
Production batches of N-Methyl-4-nitrophthalimide typically result in a crystalline powder. Appearance varies according to process route and purification but usually ranges from pale yellow to light orange. Some runs generate material with a faint, sharp odor, especially if trace residuals from intermediates are present. Melting point is process- and grade-dependent and used as a crude screen for batch identity and purity. Density fluctuates depending on means of crystallization and is used as a secondary test only where critical. Boiling point and flash point are not practically measured under standard atmospheric conditions since decomposition occurs prior to boiling.
Drafted handling methods respect the nitro functionality. In-house observations: material remains chemically stable under ambient, dry storage but can hydrolyze in persistent moist air or alkaline conditions. Trace contamination with strong acids, bases, or reducing agents from upstream can induce decomposition, so batch release only follows evidence of neutralization and drying. Nitro compounds demand careful segregation from strong oxidizers and other reactive classes during warehousing and plant logistics.
Solubility takes grade and residual impurity profile into account. It dissolves fully in polar aprotic solvents under laboratory conditions; batches intended for downstream modification must meet a defined clarity endpoint after dissolution. Industrial solution prep involves slow charge, controlled agitation, and temperature, as some batches may foam or gel if residual fines, moisture, or process aids remain in the product.
Grade distinctions reflect end-use requirements. Research, technical, and industrial grades each follow separate, internally defined purity benchmarks. Standard table entries include appearance, assay by HPLC, melting range, loss on drying, insoluble matter, and color index. Large-scale customers specify additional impurity limits relating to their process sensitivity.
Impurities originate primarily from incomplete methylation, nitration byproducts, and phthalimide-derived tars. Main control points on final release include quantification of starting material residues, isomeric impurities, and less volatile organic contaminants. Impurity levels are managed through synthesis route design, tight process monitoring, and post-processing control. Final limits depend on the selected grade and customer process impact studies.
Internal QC lab applies a mix of compendial and validated in-house analytical protocols. HPLC, GC-MS, and NMR feature in identity and purity assessments, while loss on drying and titration support material specification. Customers running GMP production require conformance to validated, mutually ratified methods and retain the option to conduct independent confirmation.
Raw material selection targets high purity N-methyl phthalimide and fuming nitric acid (or NO2 donors) with trace impurity analysis performed batchwise. Sourcing takes into consideration downstream reactivity, cost structure, and impurity burden, which can impact batch purification efficiency and waste generation.
Nitration of N-methyl phthalimide proceeds under controlled temperature and agitation, using carefully dosed nitrating agent to minimize dinitro and undesired positional isomer formation. Reaction workup includes aqueous quenching and multiple neutralization steps to destruct excess acid and isolate product efficiently.
Critical control points focus on temperature, feed rate, and acid concentration during nitration to limit decomposition and byproduct load. Purification draws on sequential filtration, crystallization, recrystallization, and vacuum drying. Exclusion of moisture and trace acid residues in the final product is regularly verified.
Batches clear internal QC after meeting grade-dependent assay, melting range, and impurity criteria. Release standards remain coordinated with long-term customer requirements, and batch records include full traceability for raw materials, process events, and deviation logs.
Typical transformations apply nucleophilic aromatic substitution at the nitro-aromatic position, hydrolysis of the imide group, and reduction of the nitro group. Many downstream products target fine chemical, pharmaceutical, or pigment markets.
Reactions generally use stoichiometric or catalytic quantities of alkali, reducing agents, or nucleophiles and require polar solvents. Batch temperature and reagent selection depend on grade, with process mandates avoiding excess heat or mechanical agitation if technical grade monomer contains insoluable fines that can seed side reactions or filter clogging.
Customers use it as a precursor to specialty dyes, pharmaceutical intermediates, and functionalized imides. Product modification routes require tight quality of starting material, especially concerning isomeric and nitro-degradation impurities, to ensure downstream yield and minimize product returns.
Material is kept in sealed original packaging, under dry and cool conditions, shielded from direct sunlight. Intermediate bulk containers and lined drums selected after compatibility testing with phthalimide and nitro compounds. Exposed to ambient humidity, product caking or minor color shift may occur, especially in technical or industrial grades.
Containers of HDPE, lined steel, or glass preserve integrity for most storage periods. Compatibility validated by aging studies for select lots. Packaging deemed unsuitable if visible corrosion, swelling, or seal degradation appears.
Shelf life estimates draw from ongoing stability trials and process history by grade. Main degradation indicators are shift in color, odor, solubility in QC solvent, and drop in assay. All lots undergo retesting if stored beyond the recommended period or after exposure to harsh environment during transit.
Classification and labeling adopt guidance from harmonized regulatory reporting, with special reference to nitroaromatic hazard classes. Nitro- and phthalimide functionalities require explicit risk communication on skin, eye, and inhalation hazards in all technical documentation and containers.
Process operators follow standard handling for toxic, oxidizable solids. Eye and skin protection required for all open handling; local exhaust or closed-system practice adopted in production and large-scale packing. Dust formation during powder transfers and sieving processes, if uncontained, may generate irritant particulate.
Handling follows best industrial hygiene standards, including qualified ventilation, containment, and medical screening for production staff. Toxicological profile and exposure limits get updated as new studies publish, with internal exposure guidelines set conservatively until official data appears. Decontamination after accidental release emphasizes dry collection followed by chemical destruction steps suited to nitroaromatic waste.
As an integrated manufacturer, we size each campaign of N-Methyl-4-nitrophthalimide according to contract duration, grade requirements, and customer-specific schedules. Typical availability reflects our plant's multi-reactor flexibility, supporting both standard and custom syntheses. Seasonal fluctuations in intermediate precursors and regulatory-driven checks influence our annual throughput. Production reallocation toward higher-purity batches or color-sensitive lots causes lead time shifts as quality control completion defines final shipment timing.
Normal lead times depend on route selection and grade, with standard technical grades achieving quickest turnaround. Pharmaceutical or electronic grades add more in-process and release analytics, which extends the delivery frame. Minimum order quantities adjust with campaign size; specialty packaging or small-scale requests require pre-scheduling to align with batch breakup logistics and packaging line preparation.
Commercial lot packaging strategies reflect moisture sensitivity, photostability, contamination control, and end-use sector. High-purity grades utilize lined drums or anti-static liners to reduce particulates and cross-contamination. For bulk orders, welded or sealed options reduce transit risk; custom pack sizes rely on pre-tested materials compatibility and hazard requirements.
Shipping terms adapt to destination hazard protocols and temperature/moisture requirements; some routes dictate protective secondary containers or cold-chain support during extended customs clearance. Payment schedule follows international commercial practice, with credit terms considered based on history, order scale, and risk profile.
The main contributors include ortho-nitrophthalic anhydride and methylamine, both of which have cost structures exposed to commodity price cycles and regional feedstock swings. Regulatory compliance costs, especially for critical-use grades, add traceability and certification steps to upstream sourcing, raising batch release costs. Energy requirements for selective nitration and purification steps are direct cost drivers.
Volatility across chemical upstreams, particularly when intermediary aromatics shift due to refinery or cracker shutdowns, prompts price swings at the starting gate. Geo-political or policy-linked changes in environmental compliance or licensing further disrupt precursor pricing. Fluctuations arise from increased certification requirements for higher-purity or regulated markets, and exceptional purity specifications sharply influence process yield loss.
The final price depends on grade specification, analytical certificate range (such as for electronics, pharma, or industrial users), and packaging certification. Grades meeting stringent impurity or trace residue standards require additional purification and segregation, directly impacting cost. Custom certification (USP, GMP, REACH, etc.) adds formal release testing and regularly requires batch-specific documentation, all of which drive up finished product pricing compared to technical grades. Packaging impacting shelf-life or cross-contamination risk (for high-sensitivity industries) adds incremental cost per lot.
Demand correlates closely with dye intermediates, specialty polymers, and select pharma intermediates. Seasonal production stoppages, major plant maintenance, or environmental audits in East Asian regions contribute to periodic tightness in global supply. Supply concentration in Asia affects price transparency and contract predictability for downstream consumers. Regional regulatory barriers or import duties in the EU and US prompt occasional domestic sourcing pushes, impacting local price floors.
Projected pricing shows sensitivity to sustained raw material volatility, environmental compliance costs, and supply chain rebuild cycles in Asia. Downstream recovery in advanced manufacturing, especially electronics and pharma, is expected to spur higher demand for high-purity and certified batches. Incremental compliance expense will translate to segmented price increases by grade and destination. Price deltas between certified and regular technical grades will likely widen.
Market insights stem from internal supply agreements, monitored contract price movements, and feedback from procurement cycles with major end users in the mentioned regions. Trends integrate published regulatory updates, global logistics cycle data, and customer-driven specification changes.
Energy price instability, trade policy shifts, and regional environmental inspections re-shape planned production schedules. Occasional interruptions in key upstream intermediates have prompted several global buyers to diversify supplier portfolios and request increased traceability for each batch.
Recent alerts from authorities in the EU and US reinforce maximum residue limits for nitroaromatic compounds in pharma and electronics. As a manufacturer, dynamic internal audit systems and real-time monitoring allow rapid adaptation to changing allowable limits or documentation protocols. Increased frequency of batch-specific reporting and analytical record-keeping has become mandatory for new supply contracts.
We deploy scheduled audits of upstream material suppliers and maintain redundant QA pathways to ensure lot conformity. In-process electronic data capture limits misidentification or process drift. Our R&D group actively screens potential process modifications to address recurring supply disruptions, with responsive customer communication protocols to inform clients of supply or compliance shifts as early as possible.
N-Methyl-4-nitrophthalimide serves as a specialty intermediate across several chemical sectors. Its main roles are in advanced organic synthesis, pharmaceuticals, agrochemical developing, and research in functional materials. In pharmaceutical research, the compound acts as a precursor for heterocyclic scaffolds and functionalized building blocks. Agrochemical projects use the molecule where nitro-phthalimide groups introduce selectivity or reactivity into experimental pesticides or seed treatments. In polymer and pigment research, it plays a part in developing specialty resins or advanced coating formulations.
| Application Field | Preferred Grade | Key Quality Requirements |
|---|---|---|
| Pharmaceutical Synthesis | High Purity | Low Organics Impurities, Tight Heavy Metals, Robust Batch Consistency |
| Agrochemical Development | Technical | Focus on Nitro-Group Content, Acceptable Volatile Impurities |
| Functional Polymers & Coatings | Industrial | Moisture Control, Color Index, Solubility Consistency |
| Academic Research | Lab/Custom | Application-specific—Agility on Purity or Isomer Ratio |
Pharmaceutical users set stringent targets for residual solvent profiles, total impurity counts, and heavy metal thresholds. Each batch undergoes detailed release checks for purity and isomer content. Agrochemical candidates often accept wider impurity bands but require precise functional group quantification and stable storage. Polymer and pigment applications may tolerate wider ranges for minor impurities yet require close attention to moisture, dust levels, and particle size distribution, impacting downstream mixing and result stability. For research use, property requests shift based on synthesis goals; often, both purity and minor component transparency are negotiated directly with technical staff.
Identify whether your work focuses on regulated drug development, scale-up crop projects, new materials, or exploratory synthesis. Applications driving human or animal health will require deeper engagement on grade traceability and batch history. Core industrial research or performance polymers may instead prioritize logistical supply and price stability.
Pharmaceutical and some agrochemical routes carry explicit regional and international requirements around allowable impurity profiles and reporting. Manufacturers tailor release parameters to comply with customer documentation and local market regulations—the technical team can match supply to the customer’s submitted specification sheets or regulatory filing needs.
Match process step criticality to the appropriate purity: final API synthesis routes demand higher analytical standards than preliminary screening studies. For research labs conducting initial screens, a standard technical or lab grade may suffice, but moving to scale means upgrading release criteria for organics, inorganics, and trace process byproducts.
Batch sizes and total order volume influence available production routes. Large-scale orders typically follow dedicated process lines, facilitating fixed impurity control and secure supply. Research scale, pilot, or high-mix low-volume orders often utilize multi-purpose assets, allowing for agile adjustment yet possibly showing broader impurity spreads, which should be reviewed with technical support.
Practical application always benefits from bench validation of a production batch. Manufacturers offer retained-sample analysis and application-specific pilot runs for customers with unique requirements or regulatory filings. The technical team provides full access to retained batch data, typical values by grade, and consultation for upstream or downstream compatibility.
Raw material grades and source selection establish baseline impurity risks—aromatic feedstocks with trace metals demand more downstream purification. Route selection (oxidative, substitution-based, or mixed route) drives differences in isomer ratios, residual solvents, and minor byproduct profiles. Key control points during nitration and methylation dictate main impurity trends.
Operators track batch consistency through in-process sampling at each critical transformation. After synthesis, purification strategies may include crystallization, solvent wash, or chromatographic enrichment, based on end-use grade. Final pack-out follows internal traceability and review, ensuring each grade hits customer-advised or standard release criteria—these are defined in dialogue with users or based on industry-specific expectations, rather than using a fixed universal specification.
Release is never based on a single absolute test; technical judgment weighs system performance across multiple runs, reproducibility checks, and comparative analytical datasets.
Our facility operates under documented quality management systems validated by external audits. The scope and rigor of quality management practices align with the grade and end-use requirements of N-Methyl-4-nitrophthalimide. For raw material traceability, in-process control, and batch release, our protocols conform to relevant ISO 9001 standards, as applicable in the specialty chemicals sector. External surveillance audits verify our adherence to regulatory and customer-driven quality benchmarks. Operational training and certification retention remain prioritized in our periodic internal reviews.
Certifications supporting N-Methyl-4-nitrophthalimide depend on downstream industry demands and geographic compliance. Where required, independent verification supports batch release. For sensitive applications, customer-driven test methods or regional regulatory requirements drive supporting documentation. Halal, REACH, or other registration protocols are provided when stipulated under the supply contract. Routine production follows the release criteria reflecting customer, regulatory, and technical usage standards.
Every shipment of N-Methyl-4-nitrophthalimide is accompanied by a lot-specific Certificate of Analysis (COA) reflecting agreed release parameters. Custom test reports addressing impurities, physical properties, and tailor-required analytical profiles are provided for specialized lots or upon request. Batch logs, change control records, and traceability dossiers are held on file and can be reviewed on site under confidentiality. Supporting SDS and transport documentation conform to regulatory submissions for each destination market.
Consistent output of N-Methyl-4-nitrophthalimide associates with in-house control of key synthesis stages and long-term supplier relationships for restricted precursors. Output volumes are reviewed based on offtake forecasts and demand variability. Adjustable supply terms support both routine and project-based orders. Volume and delivery cadence are coordinated through supply chain integration, reflecting both seasonal changes and order sensitivity.
Redundant line capability and planned maintenance ensure sustained output. Dedicated reactors are assigned to specialty chemical lines to minimize contamination and cross-reactivity events. Inventory holding policies reflect average lead times for the chemical class, with real-time adjustments based on end-customer consumption patterns. Strategic stock buffers are established for priority customers or regions with challenging logistics.
Samples of N-Methyl-4-nitrophthalimide are made available according to evaluation requirements. Request forms channel through technical service, where intended use, required documentation, and safety handling protocols are discussed prior to approval. Where there are specific grade, particle size, or purity demands, custom sampling can be arranged within feasible production limits. Sample dispatches are logged under the same traceability and test regime as full-scale batches.
Production slots, packaging formats, and documentation support are matched flexibly with contract structure. For collaborative development or scale-up needs, joint technical reviews and change controls are conducted to minimize transition risks. Order cycles, volume commitments, and pricing models can be tailored over review periods, prioritizing ongoing transparency and mutual risk mitigation. Emergency response protocols and contingency manufacturing routes are maintained for key accounts where process interruption would have downstream impact.
Research into N-Methyl-4-nitrophthalimide continues to focus on its role as a building block for specialty chemical synthesis. Laboratory teams report that its reactivity in nucleophilic substitution and cross-coupling reactions supports expanded access to advanced intermediates for electronic materials and pharmaceuticals. Process engineers place growing attention on refining crystallization techniques and developing new solvent systems to improve downstream purity.
Demand patterns show increasing integration into custom synthesis for OLED intermediates and designated pharmaceutical scaffolds. Some collaborative projects between R&D and pilot plants have explored applications in photoresist formulations and novel functional dyes, taking advantage of its nitro-functionalized arene core. Routine feedback from application partners drives adaptation in particle size distribution and surface modification to suit specific downstream reactivity.
Teams consistently encounter challenges controlling byproduct formation from methylation processes, which varies depending on the choice of methylating agent. Impurity management, notably residual phthalimide homologs, remains the principal bottleneck during scale-up. Our quality labs introduced an impurity fingerprinting workflow using HPLC and NMR, which supports faster root cause investigation. Continuous process monitoring, such as in-line spectrometry, has increased batch-to-batch consistency, but the detection limits for trace nitroaromatic impurities dictate the level of real-time intervention required.
Market trends project stable demand growth, driven by contract manufacturing in electronics and advanced pharmaceutical intermediates. Analysts expect that with expanded regulatory scrutiny on aromatic nitro compounds, supply chains will prefer partners that can document origins, processing controls, and batch genealogy. Regulatory teams anticipate region-specific compliance standards will shape end-market access for grades targeting medical and electronic segments.
Scale-up projects increasingly feature semi-continuous systems and modular purification setups. Adoption of advanced reactor designs supports finer temperature and reactant control, reducing impurity formation. Integration of solvent recovery units and energy rebalancing is emerging within larger-volume lines to address both material efficiency and regulatory mandates for emissions reduction. Select customers now request digital tracking for process deviation alerts, reflecting growing confidence in automation-augmented quality control.
Process development teams pursue greener manufacturing options by evaluating alternative methylation reagents and solvent choices that minimize hazardous byproduct loads. Efforts involve recovery and reuse of solvents such as DMF and acetonitrile, contingent on impurity profiles. Recent investments in waste neutralization infrastructure seek to meet both internal benchmarks and anticipated regulatory targets for aromatic nitro compound discharge. Specific production lines now maintain batch traceability for lifecycle analysis, supporting customer requirements for supply chain transparency.
Process chemists and application engineers provide direct consultation to support project-specific questions on reactivity, solubility, and compatibility with intended downstream processing routes. Recommendations regarding storage conditions or transportation protocols depend on shipment volume, climatic zone, and receiving facility capabilities.
The technical team reviews customer-led formulation trials, offering feedback on solvent selection, filtration, and process design based on actual plant experience with different grades and batch types. Guidance on impurity management considers the origin of raw material, process route selection, and formulation tolerance thresholds. For integration into regulated end uses, documentation bundles reflecting actual analytical records support qualification and validation runs.
Customer support teams follow up on every registered shipment to track performance in customer applications and manage feedback loops with quality control. In cases where downstream issues arise—such as unexpected impurity patterns or process fouling—the technical service unit coordinates with production to investigate root causes and issue corrective action recommendations. Replacement or remediation is determined based on a review of shipment records, dosage form, and downstream process conditions, consistent with commercial agreement terms and quality release criteria defined at the time of sale.
N-Methyl-4-nitrophthalimide has found its place in many synthetic pathways and specialty applications across several chemical sectors. As a direct manufacturer, we produce N-Methyl-4-nitrophthalimide in controlled batches, utilizing a closed-system synthesis that ensures minimal impurities and well-defined particle characteristics. Our facility has refined the process to maintain tight analytical specifications, supporting consistent performance in downstream use.
Manufacturers in pharmaceuticals, dyes, and specialty polymers incorporate N-Methyl-4-nitrophthalimide due to its reactive nitro and imide functional groups. The compound often features in advanced organic synthesis, where predictability in reactivity and purity impacts process outcomes. In pigment chemistry and fine chemicals, users depend on the stability and reproducibility seen in every lot.
Quality control remains a company-wide priority. Every batch undergoes rigorous HPLC, GC, and spectroscopic analysis in our on-site laboratory. We check for residual solvents, by-products, and trace metal content. Certificates of analysis accompany all shipments, and production logs ensure full traceability from raw material intake through to dispatch. Investing in modern analytics and process automation translates into stable material properties, shipment after shipment.
Production scale supports both standard and high-volume needs. Our packaging team fills, seals, and labels containers in a climate-controlled space, reducing the risk of product degradation. Standard packing formats include lined fiber drums and sealed HDPE pails. This approach protects the compound from moisture ingress and physical damage during transport. Various lot sizes can be supported based on production scheduling and customer forecasts.
From bench chemists to plant managers, our support team responds to technical queries with data drawn from firsthand process knowledge. We supply application guidance and troubleshooting rooted in real manufacturing experience. Often, production managers require assurance on batch-to-batch performance or specific analytical parameters. We share technical documentation, run joint QC tests, and discuss process adjustment based on end-use insight.
Procurement and supply chain specialists choosing a producer-led model reduce risk around schedule adherence, specification drift, and sector compliance. By controlling the entire production cycle, from precursor synthesis to final QC, we cut delays and eliminate source ambiguity. Commitment to forward inventory planning and buffer stock policy strengthens business continuity for all downstream manufacturers and distributors relying on regular feedstock supply.
Working on the production line for N-Methyl-4-nitrophthalimide teaches a lot about the challenges and possibilities this compound brings to the table. Chemically, it belongs to the nitro-phthalimide family, and the addition of a methyl group shifts its reactivity and handling profile compared to its parent molecules. Staff in our quality control lab always point out that the compound forms fine, off-white to pale yellow crystalline solids, which already hints at its level of purity and the care needed in the purification step.
Our chemists pay extra attention to the melting point because even slight variations signal batch-to-batch inconsistency. For N-Methyl-4-nitrophthalimide, the typical melting point falls in the region near 218–220°C. Batches that crystallize cleanly and demonstrate a sharp melting transition reflect proper manufacturing controls and minimal contamination or byproduct carryover. We run several checks through capillary method and differential scanning calorimetry to pin down the melting temperature since end users in synthesis or research look closely at this number as a mark of batch quality.
The biggest feedback we hear from formulators and developers centers on solubility. N-Methyl-4-nitrophthalimide dissolves readily in polar organic solvents such as dimethylformamide and dimethyl sulfoxide. Solubility in lower alcohols like ethanol persists up to moderate concentrations, but aqueous solubility remains low due to its aromatic and imide structure. This property suits its primary application as an intermediate in specialty chemical synthesis, where organic solvent compatibility matters most. We provide solubility guidelines as part of our technical dossier, because the right solvent often makes or breaks downstream processing success.
Demand for high-purity N-Methyl-4-nitrophthalimide keeps rising, particularly from pharmaceutical research and electronic materials sectors. Our plant routinely achieves purity above 98% by gas chromatography and high-performance liquid chromatography. Regular multistage recrystallization and in-process quality checks help us reduce contamination by unreacted starting materials and surface-adsorbed moisture. The focus isn’t just top-line figures—by reducing side reactions and batch variability, our teams help clients run safer and more consistent processes.
Investing in in-line analytics allows our production shifts to spot inconsistencies early. Our technical team spends significant hours researching the impact of solvent ratios, agitation speeds, and crystallization temperature during the final step to prevent formation of isomeric or colored by-products. Every batch gets moisture content studies along with residual solvent analysis to help ensure storage stability. Long-standing customers in the fine chemicals sector comment that these steps reduce troubleshooting time at their facilities.
Storage and shipping considerations for N-Methyl-4-nitrophthalimide bring their own challenges. While not hygroscopic, it’s sensitive to light and prolonged exposure to bases, leading to potential product degradation. Standard packaging uses light-resistant, airtight containers, and large contracts include detailed handling guidelines prepared by our safety officers. Our continuous improvement team supports clients with advice on transferring and charging the compound in scale-up operations, sharing insights learned through repeated manufacturing cycles.
Questions about order quantity and lead time come up daily from R&D teams, procurement officers, and project managers. Working as a producer of N-Methyl-4-nitrophthalimide teaches us the real drivers behind these queries: reliability, predictability, and a direct line to the people who actually make the product. Every gram that leaves our factory reflects deliberate planning and experience built over years of production, not just a fulfillment exercise. Let’s walk through what shapes the answers to these questions in practice, from the perspective of a facility that carries out the chemical synthesis, purification, and quality control in-house.
N-Methyl-4-nitrophthalimide does not lend itself to piecemeal production. Synthetic chemistry runs operate most efficiently at certain scales due to reactor volume, downstream purification needs, and safe handling of the starting nitrophthalimide. Each batch requires a fixed amount of process overhead—cleaning, setup, analytical checks. Producing sub-kilogram amounts can create more waste and potential for error, so our standard minimum is typically set at 1 kilogram. This quantity gives room to run controlled reactions, carry out purification with good yield, and ensure all QA samples are reserved through each step. For ongoing contracts where technical validation runs are needed, we have sometimes engaged in smaller batches for early-phase evaluation, provided it matches a clear project timeline and application scope.
People dependent on predictable schedules want to avoid surprises. In our experience, the shortest reliable lead time for N-Methyl-4-nitrophthalimide runs up to 4-6 weeks from confirmed order. This includes time for raw material allocation, farming out any analytical method development, actual synthesis, and repeated verification of purity. Our team carries out full traceability from reagent sourcing onward and does not shortcut batch documentation. Complex orders, multi-step scale-ups, or requests for custom specifications—not a rare situation in specialty chemicals—may add several weeks, so our baseline planning always factors in room for real-world contingencies. For repeat customers or framework agreements, advance forecasting can shorten this window.
It’s easy to underestimate how much work goes into each order before a packed drum ever leaves dispatch. We run full batch records, handle environmental controls, and guarantee identity and quality for each lot. Meeting audits and compliance reviews also shapes both minimum lots and delivery dates. Mistakes or rushed processes ripple down the value chain, often with costly results for process engineers or formulation teams by the time material lands at their plant. Consistency in minimum order quantity and lead time keeps expectations grounded and allows everyone—from lab technicians to plant managers—to plan confidently.
Direct conversation streamlines custom project setup and helps match demand with production runs. We encourage partners to share upcoming project loads or regulatory requirements early so we can align production schedules, batch sizes, and allocation of specialist staff. This advance notice shrinks bottlenecks and lets us explore options like long-term stock agreements or staggered shipments to fit evolving demand. Transparent dialogue allows quicker technical troubleshooting and adaptation, so everyone in the value chain benefits from a steadier, more reliable supply.
N-Methyl-4-nitrophthalimide stands as a prime example of how minimum order quantities and lead times reflect not just pure logistics, but also the operating realities and responsibilities at the chemical manufacturing level. Every decision about these parameters stems directly from years of hands-on production and the feedback from partners who depend on our quality and consistency.
Direct involvement in the production and packaging of N-Methyl-4-nitrophthalimide gives us a clear view of the practical and legal safeguards needed for shipping. Safety forms the backbone of our logistics process at every stage, from handling bulk material in our own warehouse to final dispatch. Our team remains vigilant to transport requirements tied to nitro compounds and imide derivatives, since oversight places customers, carriers, and personnel at risk.
N-Methyl-4-nitrophthalimide sits in a regulatory space influenced by its nitro group and organic imide structure. Compounds bearing these features often attract attention under various transport frameworks due to concerns surrounding explosivity, flammability, and toxicity. We verify each new lot through a hazard classification assessment referencing international chemical lists, including the UN Recommendations on the Transport of Dangerous Goods and the GHS system. Consultations with our safety advisors keep us aligned with evolving rules, primarily under the ADR, IMDG, and IATA DGR codes.
Through our own review and third-party studies, N-Methyl-4-nitrophthalimide does not appear on every standardized list as a regulated “dangerous good,” though its composition demands close scrutiny. We look at UN numbers relevant to nitro-substituted phthalimides or related aromatic nitro intermediates and track their status for classification. Cases exist where local laws place stricter requirements than international rules. Our regulatory team handles both chemical inventory status and shipment classification, always prioritizing full documentation, including Safety Data Sheets formatted in line with GHS requirements and compliant with the shipping country’s law.
Our packaging lines operate to ensure complete product integrity and containment in transit. We use sealed HDPE, fiber, or metal drums, with extra consideration for palletizing and secondary containment if requested. Each lot carries documentation confirming batch traceability. MSDS sheets travel with every consignment. In our practice, even where N-Methyl-4-nitrophthalimide falls outside strict hazardous material rules, we apply conservative procedures typical for transport of analogs in the same chemical family. Clear, up-to-date labeling addresses legitimate customs and carrier concerns and accelerates border clearance in complex regulatory environments.
We have seen shipments flagged for clarification on nitro group content, particularly for air and sea freight. This leads our logistics team to remain especially vigilant about packaging integrity, drop-testing, and ensuring packaging certification meets both UN and carrier requirements. Solid communication with freight handlers avoids confusion at ports or cargo depots. Our records show that strictly following best chemical shipping practices substantially reduces delays and accidental exposures.
We never assume regulatory stability. Our compliance unit tracks each update to dangerous goods lists issued by IATA, IMDG, and major regulatory bodies. As direct manufacturers, we maintain incident logs, employee training records, and full traceability for shipped goods. Where authorities introduce new rules around chemicals containing nitro or imide groups, we prepare safety and shipping data revisions well in advance. Expert consultation remains a permanent part of our routine, not an afterthought.
We recommend regular checks of transit documentation and labeling, periodic re-evaluation of packaging, and ongoing internal audits of shipping protocols. Continuing education of warehouse and logistics staff about chemical compatibility and incident management forms part of our culture. This approach allows us to balance efficiency and safety in the movement of N-Methyl-4-nitrophthalimide and related specialty chemicals.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
